PedAM
Pediatric Disease Annotations & Medicines
| Disease | polycystic kidney diseases |
| Phenotype | C0035304|retinal degeneration |
| Sentences | 1 |
| PubMedID- 26064426 | Through mtor, epo protects vascular cells [67, 173], prevents cell injury during β-amyloid (aβ) exposure [170], modulates bone homeostasis [167], promotes retinal progenitor cell survival during oxidant stress [169] and blocks retinal degeneration in models of polycystic kidney disease [86], promotes the neuronal phenotype of adult neuronal precursor cells [168], improves cognitive function in sepsis-associated encephalopathy [171], and limits cell injury during oxygen-glucose deprivation [174, 175]. |
Page: 1